Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment
Flu Vaccine Efficacy Examined in Southern Hemisphere Countries
Adjusted vaccine efficacy was 36.5 percent against the predominant subtype A(H3N2) and 37.1 percent against A(H1N1)pdm09
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years
Cancer Survival Rates Rose for Young Adults After Affordable Care Act
Benefits seen for young adults eligible for dependent care expansion
California Reports Two Cases of Bird Flu in Dairy Workers, a First for the...
One in Nine Primary Care Visits Is for a Mental Health Issue
Only musculoskeletal conditions accounted for a greater share of visits
Immunity From Mpox Vaccine May Be Waning
Regardless of one or two doses, mpox antibodies wane by six to 12 months
Fear of Cancer Recurrence Common Decades After Surviving Childhood Cancer
Fear also tied to worse mental and physical health
Bright Light Therapy Effective for Nonseasonal Depressive Disorders
Better remission and response seen with bright light therapy before four weeks and after four weeks
2021 USPSTF Recommendation Boosted Colorectal Cancer Screening
Potential disparities in uptake seen by socioeconomic status and locality among privately insured adults
